Opportunity Information: Apply for PA 11 134
Apply for PA 11 134
- The National Institutes of Health in the education food and nutrition health sector is offering a public funding opportunity titled "Lab to Marketplace Tools for Brain and Behavioral Research (SBIR R43/R44)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.173 Research Related to Deafness and Communication Disorders 93.213 Research and Training in Complementary and Integrative Health 93.242 Mental Health Research Grants 93.273 Alcohol Research Programs 93.279 Drug Abuse and Addiction Research Programs 93.361 Nursing Research 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders 93.866 Aging Research.
- This funding opportunity was created on Feb 25, 2011 and posted on Feb 25, 2011.
- Applicants must submit their applications by Jan 7, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Small businesses.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
Lab to Marketplace Tools for Brain and Behavioral Research (SBIR R43/R44), Funding Opportunity Number PA-11-134, was a National Institutes of Health (NIH) Small Business Innovation Research (SBIR) grant opportunity tied to the NIH Blueprint for Neuroscience Research. The Blueprint is a cross-NIH framework designed to strengthen cooperation among the NIH Office of the Director and 15 participating NIH Institutes and Centers that support research on the nervous system. Under this announcement, multiple Institutes and Centers could participate independently, and participation was also open to NIH components outside the Blueprint, reflecting a broad NIH-wide interest in accelerating neuroscience-related technology dissemination.
The main purpose of the opportunity was to move practical technologies for brain and behavioral research out of academic labs and other non-small-business settings and into the commercial marketplace, where they could be broadly distributed and maintained as usable products. Rather than funding basic discovery science, the FOA emphasized translation and productization: taking tools that already exist in some form and investing in the work needed to make them strong, reliable, and ready for real-world adoption by the research community. In practice, that meant SBIR projects focused on further development, engineering, validation, user experience improvements, packaging, documentation, and other steps that increase robustness and usability so the technology can be disseminated commercially.
Eligible applicants were Small Business Concerns (SBCs), consistent with SBIR rules and the R43/R44 mechanism structure (generally corresponding to Phase I and Phase II activities). The announcement explicitly anticipated that successful projects would often require close collaboration between the original inventors or academic developers of the technology and the small business responsible for commercialization. It recognized several ways to structure that collaboration, including formal partnerships and the use of multiple principal investigators, which can be important when both scientific leadership and product-development leadership are central to success.
The opportunity was categorized as a discretionary grant within health-related research and development and was associated with multiple CFDA program areas spanning neuroscience and behavioral health. These included research programs related to deafness and communication disorders (93.173), complementary and integrative health (93.213), mental health (93.242), alcohol research (93.273), drug abuse and addiction (93.279), nursing research (93.361), diabetes and digestive and kidney diseases extramural research (93.847), neurosciences and neurological disorders extramural research (93.853), and aging research (93.866). This spread signals that the tools of interest could support many NIH mission areas as long as they enable or improve brain and behavioral research.
Administrative details show the FOA was posted and created on February 25, 2011, did not require cost sharing or matching, and had an original (and final) closing date of January 7, 2014, with an archive date of February 7, 2014. The full announcement was hosted on the NIH grants site at http://grants.nih.gov/grants/guide/pa-files/PA-11-134.html, and NIH’s Office of Extramural Research (OER) webmaster contact was provided for access or linking issues.
FAQs: Lab to Marketplace Tools for Brain and Behavioral Research (SBIR R43/R44) - PA-11-134
What is the name of this grant opportunity?
The opportunity is titled Lab to Marketplace Tools for Brain and Behavioral Research (SBIR R43/R44).
What is the Funding Opportunity Number (FOA)?
The Funding Opportunity Number is PA-11-134.
Which federal agency offered this opportunity?
This was offered by the National Institutes of Health (NIH) as a Small Business Innovation Research (SBIR) opportunity.
What program or initiative was this opportunity tied to?
This FOA was tied to the NIH Blueprint for Neuroscience Research, a cross-NIH framework intended to strengthen cooperation among the NIH Office of the Director and participating NIH Institutes and Centers that support nervous system research.
What was the main goal of PA-11-134?
The main goal was to move practical technologies for brain and behavioral research out of academic labs and other non-small-business environments and into the commercial marketplace, so the tools could be broadly distributed, supported, and maintained as usable products.
Was this opportunity focused on basic science or translation to products?
This FOA emphasized translation and productization rather than basic discovery science. It focused on improving tools that already exist so they become robust, usable, and ready for real-world adoption by the research community.
What kinds of project activities were emphasized?
Projects were expected to focus on activities such as further development, engineering, validation, user experience improvements, packaging, and documentation, and other steps that improve robustness and usability for commercial dissemination.
Who was eligible to apply?
Eligible applicants were Small Business Concerns (SBCs), consistent with SBIR rules and the R43/R44 mechanism structure (generally corresponding to Phase I and Phase II activities).
What do the R43 and R44 mechanisms correspond to?
Within the SBIR structure, R43 generally corresponds to Phase I activities and R44 generally corresponds to Phase II activities.
Was collaboration with academic inventors expected or encouraged?
Yes. The FOA anticipated that successful projects would often require close collaboration between the original inventors or academic developers of the technology and the small business responsible for commercialization.
How could collaboration be structured under this announcement?
The announcement recognized multiple ways to structure collaboration, including formal partnerships and the use of multiple principal investigators, especially when both scientific leadership and product-development leadership were central to success.
Which NIH components could participate?
Under this announcement, multiple NIH Institutes and Centers could participate independently. Participation was also open to NIH components outside the Blueprint, reflecting broad NIH-wide interest in accelerating dissemination of neuroscience-related technologies.
What type of grant category was this?
The opportunity was categorized as a discretionary grant within health-related research and development.
What research areas or NIH mission areas could the tools support?
The FOA was associated with multiple CFDA program areas spanning neuroscience and behavioral health, indicating tools could support many NIH mission areas as long as they enable or improve brain and behavioral research.
Which CFDA program areas were associated with this opportunity?
The associated CFDA areas listed for this opportunity included:
- 93.173 - Deafness and Communication Disorders
- 93.213 - Complementary and Integrative Health
- 93.242 - Mental Health
- 93.273 - Alcohol Research
- 93.279 - Drug Abuse and Addiction
- 93.361 - Nursing Research
- 93.847 - Diabetes and Digestive and Kidney Diseases Extramural Research
- 93.853 - Neurosciences and Neurological Disorders Extramural Research
- 93.866 - Aging Research
Did the FOA require cost sharing or matching funds?
No. The administrative details stated that cost sharing or matching was not required.
When was PA-11-134 posted and created?
The FOA was posted and created on February 25, 2011.
What was the original (and final) closing date for applications?
The original and final closing date was January 7, 2014.
When was this funding opportunity archived?
The archive date was February 7, 2014.
Where could applicants find the full FOA text?
The full announcement was hosted on the NIH grants website at: http://grants.nih.gov/grants/guide/pa-files/PA-11-134.html
Who was listed as the contact for access or linking issues?
The FOA provided the NIH Office of Extramural Research (OER) webmaster as the contact for access or linking issues.
What does "Lab to Marketplace" mean in the context of this FOA?
In this FOA, "Lab to Marketplace" referred to taking practical research tools that exist in a lab or other non-small-business setting and investing in the work needed to make them commercially distributable, maintainable, and broadly usable by the research community.
What kinds of technologies were most aligned with the FOA's purpose?
Based on the description, technologies most aligned were tools for brain and behavioral research that already exist in some form and need additional development work to become strong, reliable products suitable for wide dissemination and ongoing support.
Browse more opportunities from the same category: Education Food and Nutrition Health
Next opportunity: ENGAGE Learning to Solve Problems, Solving Problems to Learn
Previous opportunity: Complex Technologies and Therapeutics Development for Mental Health Research and Practice
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 11 134
[Watch] how do funding administrators access proposals?
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 11 134", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.